RankingsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Free cash flow

ABBOTT LABORATORIESABT

Market cap
$223B
P/E ratio
SummaryFinancials
Period EndFree cash flow (Million USD)YoY (%)
Dec 31, 20246,351+25.54%
Dec 31, 20235,059-35.17%
Dec 31, 20227,804-9.76%
Dec 31, 20218,648+51.08%
Dec 31, 20205,724+27.26%
Dec 31, 20194,498-8.32%
Dec 31, 20184,906+10.62%
Dec 31, 20174,435+113.02%
Dec 31, 20162,082+12.18%
Dec 31, 20151,856-28.56%
Dec 31, 20142,598+19.23%
Dec 31, 20132,179-71.02%
Dec 31, 20127,519+0.54%
Dec 31, 20117,479-3.14%
Dec 31, 20107,721

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)